Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 4 of 4 entries
View as:
Phase: N/A
Priority: Normal
Start: 08/31/13
End: 05/31/14
Due: 05/31/15
Phase: N/A
Priority: Normal
Start: 07/31/14
End: 02/28/15
Due: 02/28/16
Phase: N/A
Priority: Normal
Start: 03/31/13
End: 05/31/14
Due: 05/31/15
Phase: N/A
Priority: Normal
Start: 11/30/15
End: 07/29/16
Due: 07/29/17
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Prospective Evaluation of Reduced Impedance Noninvasive Cortical Electrostimulation (RINCE) to Reduce Fibromyalgia Effects - Extension Study | NCT01958853 | Cerephex Corporation | user2@example.com | None | 2013-08-31 | 2014-05-31 | 2015-05-31 | - | - | 2025-07-14 |
| Prospective Evaluation of RINCE to Reduce Fibromyalgia Effects - 301 | NCT02211508 | Cerephex Corporation | user2@example.com | None | 2014-07-31 | 2015-02-28 | 2016-02-28 | - | - | 2025-07-14 |
| Prospective Evaluation of RINCE to Reduce Fibromyalgia Effects - St. Joseph Mercy Oakland | NCT01825954 | Cerephex Corporation | user2@example.com | None | 2013-03-31 | 2014-05-31 | 2015-05-31 | - | - | 2025-07-14 |
| Prospective Evaluation of RINCE to Reduce Fibromyalgia Effects - 202 | NCT02613949 | Cerephex Corporation | user2@example.com | None | 2015-11-30 | 2016-07-29 | 2017-07-29 | - | - | 2025-07-14 |